<DOC>
	<DOCNO>NCT01077310</DOCNO>
	<brief_summary>This randomize controlled trial injectable intramuscular naltrexone ( XR-NTX ) versus intramuscular placebo among HIV-infected prisoner meet Diagnostic Statistical Manual Mental Disorders , Fourth Edition ( DSM-IV ) criterion alcohol dependence problem drinking , transition community seek treatment prevent relapse alcohol use . We hypothesize extended release naltrexone ( XR-NTX ) result improve HIV outcome ( low log10 HIV-1RNA level higher CD4 count ) well improve alcohol treatment outcome , reduce drug/sex HIV relate risk behavior decrease rate reincarceration .</brief_summary>
	<brief_title>Alcohol Pharmacotherapy HIV+ Prisoners</brief_title>
	<detailed_description>INSPIRE randomize control trial injectable intramuscular NTX ( XR-NTX ) versus intramuscular placebo among Human Immunodeficiency ( HIV ) infect prisoner meet DSM-IV criterion alcohol dependence problem drinking , transition community seek treatment prevent relapse alcohol use . While COMBINE trial demonstrate effectiveness oral naltrexone group active alcohol dependent person decrease relapse alcohol use placebo , naltrexone studied people history current alcohol dependence prior incarceration , incarcerate actively use alcohol likely return alcohol use release . In study , conduct placebo-controlled trial determine naltrexone effect group , could important make case naltrexone available alcohol dependent problem drinking HIV+ prisoners prior release . We compare HIV treatment ( HIV-1 RNA level , CD4 count ) , alcohol treatment ( time relapse heavy drinking , percent day drinking , percent day abstinent alcohol crave ) HIV risk behavior ( sexual drug-related risk ) outcomes . The hypothesis include : i. XR-NTX result improve HIV clinical outcome , include change HIV-1 RNA level , high CD4 count . ii . XR-NTX result improve alcohol treatment outcome , include long time alcohol relapse , low percent day drinking , low crave alcohol .</detailed_description>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Alcoholism</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>1 . HIV+ 2 . Inmates return New Haven Hartford 3 . Meets criteria alcohol dependence ( use Diagnostic Statistical Manual IV ) problem drinking ( use Alcohol Use Disorder Identification TestAUDIT ) 4 . Gives inform consent 5 . English Spanish speaker 6 . &gt; 18 yrs 1 . On opiate pain medication express need 2 . Aspartate aminotransferase ( AST ) Alanine aminotransferase ( ALT ) &gt; 5x upper limit normal 3 . Evidence Child 's Pugh Class C cirrhosis 4 . Pending felony charge 5 . Pregnant unwilling take contraceptive measure 6 . Subject part another pharmacological research study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>HIV</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>Alcohol dependence</keyword>
	<keyword>CD4</keyword>
	<keyword>HIV-1 RNA</keyword>
	<keyword>Alcohol treatment outcome</keyword>
</DOC>